⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

June 29, 2010Diabetes CareOpen Access

Diabetes and the Severity of Pandemic Influenza A (H1N1) Infection

R. W. Allard Pascale Leclerc Claude Tremblay Terry-Nan Tannenbaum

View Full Paper

Ask AI

Bookmark

Share

Ask about this paper

Answers are grounded in this paper and cite their sources.

Ask your own question…

Abstract

Diabetes triples the risk of hospitalization after influenza A (H1N1)p and quadruples the risk of ICU admission once hospitalized.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Allard et al. (2010) studied this question.

synapsesocial.com/papers/69d9603c04deaa6ab56842cc https://doi.org/10.2337/dc09-2215

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 10 related papers. Consider them for comparative context:

1Increased Risk of Common Infections in Patients with Type 1 and Type 2 Diabetes MellitusCohort Study · 2005 · 1,041 citations
2Impact of diabetes mellitus on mortality associated with pneumonia and influenza among non-Hispanic black and white US adults.Original Research · 1999 · 139 citations
3Critically Ill Patients With 2009 Influenza A(H1N1) in MexicoRetrospective Study · 2009 · 840 citations
4Critically Ill Patients With 2009 Influenza A(H1N1) Infection in CanadaCohort Study · 2009 · 1,425 citations
5Factors Associated With Death or Hospitalization Due to Pandemic 2009 Influenza A(H1N1) Infection in CaliforniaOriginal Research · 2009 · 1,020 citations
6Diabetes and the Risk of Infection-Related Mortality in the U.S.Cohort Study · 2001 · 270 citations
7Common Genetic Variants Near SLC2A2 and Glycemic Response to Glimepiride in the GRADE Comparative Effectiveness Clinical TrialDiabetes Care · 2026
8Longitudinal Changes in Exocrine Biomarkers in Children at Risk of Type 1 Diabetes in the ENDIA StudyDiabetes Care · 2026
9Reactions to Race[ism]: The Relationship Between Differential Treatment Based on Race and Diagnosed Diabetes Status in U.S. AdultsDiabetes Care · 2026
10A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Acmopatide (CT-868), a Fully Biased GLP-1/GIP Receptor Agonist, in Adults With Type 1 Diabetes and Overweight or ObesityDiabetes Care · 2026

More from Diabetes Care

More from McGill University

More from Université de Montréal